WO1993006713A1

WO1993006713A1 - Monocot having dicot wound inducible promoter

Info

Publication number: WO1993006713A1
Application number: PCT/US1992/008359
Authority: WO
Inventors: Ray Wu; David Mcelroy; Deping Xu
Original assignee: Cornell Research Foundation, Inc.
Priority date: 1991-10-02
Filing date: 1992-09-30
Publication date: 1993-04-15
Also published as: JPH07503126A; EP0666921A1; EP0666921A4

Abstract

The present invention describes the activity of a dicot wound inducible promoter in a monocot plant, the use of a monocot intron to enhance the activity of a dicot promoter in a transgenic monocot, and genetic constructs to introduce an exogenous genetic trait into a monocot plant using a wound inducible dicot promoter system.

Description

MONOCOT HAVING DICOT WOUND INDUCIBLE PROMOTER

This patent application is a continuation in part of United States Patent Application 762,680, filed September 18th 1991 , which in turn is a continuation of United States Patent

Application 07/461 ,490, filed January 5th 1990, now abandoned. Extensive research into the effects of proteinase inhibitors on insects first began about 1955 when it was found that a protein fraction from soybeans inhibited the growth, as well as in vitro proteolytic enzyme activity of the meal worm [see Food Chem. 2:410 (1954)]. Eventually this line of research led to the discovery of wound inducibility of two proteinase inhibitor proteins, referred to as potato inhibitor I (Pinl) and potato Inhibitor II (Pinll) proteins, in plant leaves in response to insect attack [see Science 175:776 (1972)]. One of these inhibitors, Potato inhibitor II, was determined to be an inhibitor of both trypsin and chymotrypsin proteinases. Subsequent research showed these two proteinase inhibitors to be small proteins which were not present in unwounded leaves of young plants, but which could be induced to accumulate in leaves within 4 to 6 hours following wounding. Furthermore, the inhibitors were found to accumulate in both wounded and unwounded leaves of wounded plants, thus indicating that a systemic signal was generated at the wound sites and travelled rapidly throughout the plant.

Insect damage to plant leaves can cause a dramatic increase in the levels of protease inhibitor in various plant parts, apparently as a defensive response of the plants. Using tomato plants, Broadway [see Entomol. Exp. Appl. 41 :33 (1986)] demonstrated that leaves from plants which had been induced by wounding could accumulate over 200 μg protein per gram of leaf tissue of potato protease inhibitors I and II. This amount was sufficient to severely reduce the growth rate of the beet armyworm. In direct tests used to determine the roles of proteinase inhibitors to defend against insect damage [see Nature 330:160 (1987)], transformed tobacco plants expressing a foreign cow pea trypsin inhibitor (an antinutrient agent against a wide range of insects including larvae of Heliothis, Spodoptera, Diabrotica, and Tribolium - all agronomically important insect pests) gene and producing about 1% of leaf proteins as the inhibitor were more resistant to feeding by larvae of Heliothis virescens than untransformed control plants or transformed plants that did not express the gene. Recent reports have also indicated that leaves of tobacco plants transformed with genes encoding the Inhibitor II proteins expressed the Inhibitor II proteins at levels of 50 μg/g tissue (or more), when supplied to larvae of Maπduca sexta as their only food source, caused inhibition of larval growth and eventual death.

The premise upon which studies involving wound inducible expression of inhibitor proteins has been based is that the plants produce such inhibitors as a defensive reaction to an insect attack upon plant integrity. Support for this premise is that the inhibitors appear only after a wounding; prior to an insect eating away or otherwise disrupting the plant structure, the inhibitor is not present in the plant tissue. Wound inducible inhibitor proteins have been extensively studied both in plants genetically inherently capable of inhibition expression upon wounding, and in plants not inherently capable of inhibitor expression upon wounding but which have been transformed with the genetic information required to bring about expression of the inhibitors upon wounding. However, prior to the making of the present invention, there has been nothing reported in the scientific literature indicating the successful activation of a dicot wound inducible promoter in a monocot plant; in addition, the present invention is the first report of the successful use of a monocot intron being used to enhance the activity of a dicot promoter in a transgenic monocot. As used in accordance with the present invention, "monocot" refers to plants belonging to the subclass Monocotyledoneae, and "dicot" refers to plants belonging to the subclass Dicotyledoneae. Among the commercially important monocots which may be transformed with the wound inducible promoter according to the present invention are rice, wheat, barley, oats, sorghum, and maize. Within the following description of the present invention, the use of rice is meant to be descriptive of the monocot subclass of plants; the present invention should not be considered to be limited to only rice.

Also as used in accordance with the present invention, "foreign gene of interest" refers to a gene encoding for the expression of proteins having natural insecticidal or antiviral activities in transgenic monocot plants, and also encompasses a plurality of genes having mixed insecticidal and antiviral activities. The insecticidal protein genes include the potato protease inhibitor II and inhibitor I genes, cowpea trypsin inhibitor gene (CPTi), and various Bacillus thurigiensis endotoxin genes. The antiviral genes include genes which express proteins which control insect-transmitted viral diseases, including but not limited to tungro virus, dwarf virus, black-streaked dwarf virus, and hoja blanca virus infection, and are based upon viral coat protein, antisense RNA, or an enzymatic requirement for viral infection, replication, or release. The foreign gene of interest may be substituted in place of the Gus coating regions, or inserted at an appropriate site within the expression vectors, depicted in the accompanying drawings.

The loss of rice yield due to insect pests is estimated to be at least several billion dollars a year [see Heinrichs, E.A., F. G. Medrano, and H. R. Rapusas, Genetic Evaluation For insect

Resistance in Rice, pg 1 , IRRI, Los Banos, Philippines (1985)]. The important insect pests of rice include yellow stemborer, striped stemborer, leaffolder, gall midge, brown planthopper, whitebacked planthopper, and green leafhopper. It is also known that several devastating viral diseases are transmitted by insects as, for example, tungro virus, dwarf virus, black-streaked dwarf virus, and hoja blanca virus, all of which are known to be transmitted by rice planthoppers or leafhoppers. Most insects have trypsin or chymotrypsin-like proteases in their digestive systems. Thus, introducing the appropriate protease inhibitor genes into rice plants should make the plants insect tolerant - the premise upon which the research that went into the making of the present invention was conducted. Reducing insect predation will also minimize the transmission and spreading of certain insect-borne viral diseases. It is obvious that the production of insect-tolerant plants by introducing genes encoding protease inhibitors or other natural insecticides, such as Bacillus thuringiensis (B.t.) endotoxins [see Critical Rev. BiotechnoL 6:163 (1987)] into plants is much preferred over the spraying of plants with synthetic chemical insecticides.

The different B.t. toxins have been used to kill insects by spraying plants with the crude B.t. toxins. The B.t. toxins are specific for lepidopteran insects and exhibit no harmful activity against humans, other vertebrates, and beneficial insects. Thus, the genes of these insect-killing proteins are attractive candidates for genetic engineering of crop plants for protection against lepidopteran pests.

Proteinase inhibitors provide natural defenses against insect attack by acting on the primary digestive enzymes in certain insects. Proteinase inhibitors present in dicot plants have been found to be active against a wide range of insects [see BioEssays 10:20 (1989)]. The potato gene family encoding the serine-type proteinase inhibitor II (Pinll) is by far one of the best analyzed systems of systemic gene activation in response to insect attack [see EMBO 8:1323 (1989); and Proc. Natl. Acad. Sci. USA 87:7205 (1990)]. Pinll is constitutively expressed in the tubers and young floral buds of normal greenhouse grown potato plants. However, when potato leaves are mechanically wounded to mimic the attack of a chewing insect, Pinll gene expression is induced not only in the wounded leaves, but also in the upper and lower leaves and upper part of the stem. When the promoter of a potato Pinll fused to a β-glucuronidase (Gus) reporter gene was introduced into potato and tobacco plants, the Pinll-Gus gene activity was found to follow the same pattern of expression as the endogenous Pinll gene in potato. When expressed at relatively high levels, the production of proteinase inhibitors has resulted in insect-tolerant transgenic tobacco plants [see Nature 330:160 (1987); Out. Ag. 18(1 ) (1989); and Proc. Natl. Acad. Sci. USA 86:9871 (1989)]. Although the techniques necessary for introducing the the constructed gene into monocots follow those for introducing the gene into potato, tobacco or other dicot species, prior to the making of the present invention, a foreign gene fusion containing a dicot wound inducible promoter, has not been successfully expressed in a monocot.

Since the potato protease inhibitor II inhibits both trypsin and chymotrypsin-like proteases, it was selected as the first choice for introducing Pinll-containing constructs according to the present invention into a monocot. Rice is a major crop in the world and the the techniques have been developed and used for many years in transforming and regenerating this monocot. In addition, rice can easily be grown under greenhouse conditions, has a relatively short germination to maturity period, and a number of plants can be grown in a relatively small area. Thus, rice was selected for the initial research leading to the present invention.

Purified B.t. endotoxins have had a long history of safe use as insecticides because they are non-toxic to non-target organisms and are rapidly biodegraded in the environment [see

Tibtech. 9:197 (1991)]. However, their use has been limited by the low stability of the B.t. protein in the field and the relatively high cost of B.t. toxin production and application. In general, single B.t. endotoxins display a narrow range of target insects. Several genes encoding different B.t. toxins have been cloned and the expression of individual B.t. toxin genes has been widely studied in transgenic dicot plants [see Plant Physiol. 85:1103 (1989)]. The present invention was approached with the goal that if the production of B.t. endotoxin could be expressed in transgenic rice plants, this should preclude the need for repeated spraying of field crops with expensive insecticides, and kill the target insects before significant damage could occur. However, the major potential disadvantage to expressing B.t. endotoxins in transgenic plants, whether monocots or dicots, is that insect resistance might develop over a period of time.

When using transgenic plants expressing one or a variety of natural insecticides, the aim should be to keep selection pressure for the insects as low as possible in order to minimize the development of resistant pests. Restricting the expression of such natural insecticides to those plant tissues which are most susceptible to pest damage should decrease selection pressure while still providing adequate protection. Constitutive and high- level expression of a foreign gene in plants may have undesirable effects on the growth and development of the plants. Thus, an aspect of the research leading to the present invention was to produce transgenic plants that express foreign genes of interest, and mainly natural insecticides such as B.t. endotoxins or cow pea trypsin inhibitor, only in direct response to specific insect associated damage. This aspect led to the present invention of utilizing a dicot wound-inducibie promoter for bringing about expression of a naturally occurring insecticide in a monocot plant. In simplest terms, the broad prime aspect of the present invention is to describe the use of a modified Pinll promoter system based upon the wound inducible expression of a foreign gene of interest in monocot plants. These and other aspects of the present invention will become clearer in reference to the following description and appended figures in which

Figure 1 is a depiction of various genetic constructs made in accordance with the present invention; and Figure 2 is a depiction of various expression vectors according to the present invention.

The initial step in making the present invention was to determine whether the Pinll promoter from a dicot plant could be incorporated into a monocot plant, and if so, whether the promoter would function and respond to wounding. As described in our earlier United States Patent Application 07/762,680, filed September 18th 1991 , the disclosure of which is incorporated in toto herein, the 5' intron of the rice actin 1 gene (Act1 ), when inserted between the cauliflower mosaic virus CaMV35S gene promoter and the β-glucoronidase (GUS) reporter gene greatly stimulated GUS activity in transformed rice protoplasts, a construct of the Act1 intron inserted between the Pinll promoter and Gus reporter (which is replaced by a foreign gene of interest in accordance with the ultimate uses of the present invention) gene was constructed to determine if GUS activity would be stimulated.

Initially, the following two chimeric plasmids were constructed and used for transformation: Pinll promoter - Gus reporter Pinll promoter - Act1 intron - Gus reporter.

More specifically, the use of the 5' intron from the rice Act1 gene to increase foreign gene expression from the promoter , of the potato wound inducible protease inhibitor II gene (Pinll) in transgenic rice. The 5' intron of the rice Act1 gene was found to significantly enhance the activity of the potato Pinll promoter in transient assays of transformed protoplast as shown in the following table: Construct Structure Mean GUS Specific

Names Activity (nmol/hr/mg)

pDX106 Pinll promoter-Gus coding region-Nos 3' 0.5 pDX107 Pinll promoter-Actl 5' iπtron-Gus coding region-Nos 3' 210.0 pDX108 Pinll promoter-Gus coding region-Pinll 3" 0.5 pDX109 Pinll promoter-Actl 5' intron-Gus coding region-Pinll 3' 121.0 pAct1-D Act1 promoter-Gus coding region-Nos 3' 213.8

In the above table and throughout this description, Nos 3' refers to nopaline synthase gene 3" noncoding regions. In stable transformation experiments, rice protoplasts (4-10 X 10⁶) were co-transformed with a Pinll-based fusion plasmid (80 μg) and a selectable Act1 -bar (glufosinate-ammonium resistant gene) construct (20 μg) using techniques described in United States Patent Application 07/762,680 and those well known in the art [see Theor. App. Genet. 76:835 (1988)]. Resistant calli were selected on 4 mg/l glufosinate ammonium using well known techniques. Each individual transformation produced between 400 and 600 resistant calli. Plantlet regeneration efficiency from resistant calli was between 10% and 20%, and the mean co- expression frequency was 65% for Act1 5' intron-containing Pinll-based fusion constructs.

The results from futher analysis in transgenic rice plants, using those plasmids described in the above table and shown in Figure 1 , indicated that transgenic rice plants harboring the Pinll - Gus construct produced low levels of GUS activity. However, the GUS activity was increased at least fifty-fold by the modified construct containing the Act1 intron. More importantly, GUS activity was greatly stimulated by mechanical wounding of the shoots of transgenic plants. The wound inducible effect is systemic because gentle wounding of a rice shoot in two small regions resulted in high level of GUS activity in the entire shoot. This finding is significant since, to our knowledge, there is no wound-inducible promoter that is known to function in rice or other cereal crops within the monocot subclass.

The wound inducible expression of natural insecticides at high levels in monocot plants using this modified Pinll promoter system should provide adequate protection against insect attack. At the same time, as the insecticide is not expressed until such time as the plant is wounded or attacked by insects, and as the life of these insecticides in the plant is relatively short - measured in hours - the use of the promoter system should reduce the selection pressure on the development of resistant insects. In order to localize the GUS activity driven by the Pinll promoter, the tissue specific expression of the various Pinll-Gus and Pinll-Act1 5' intron-Gus constructs in wounded and non- wounded transgenic rice plants were assayed histochemicaliy using the GUS substrate, 5-bromo-4-chloro-3-indolyl-β-D- glucuronic acid (X-Gluc); tissues showing blue coloration are indicative of Gus activity. In rice the Pinll-Gus fusion construct showed relatively weak response to mechanical wounding. However, inclusion of the Act1 5' intron in the Pinll-Gus fusion construct resulted in a high level wound-inducible response in stably transformed rice plants. The response was systemic and - was not transmitted to tillers that ^'were not connected to the wounded shoot by a common vascular system.

In order to make the wound-inducible promoter system according to the present invention more easily used for different applications, a number of Pinll-based vectors were developed using techniques which have become well known and conventional in the art. The structure of the various Pinll-based expression vectors are shown in Figure 2, The strategy for the construction of these vectors was (1) to isolate the Pinll 3' end as a 1 kbp Xbal-Sphl restriction fragment from pDXP3, and to clone this into the plasmid pCOR116 [see Mol. Gen. Genet. (1991)] to produce the vector pDX316; (2) to isolate the Pinll promoter-Actl 5' intron-Act1/Gus translational fusion junction region from plasmid pDX107 as a 1 kbp Pstl-Smal restriction fragment and clone this into the plasmid pBluescriptll-KS (Stratagene) to produce Pinll-based expression vector pDX227 (this is translational fusion vectors containing the translation initiation codon from the Act1 gene followed by a polylinker region); (3) to remove the Act1 5' intron and Act1/Gus translational fusion junction region from plasmids pDX107 and pDX 109 as a 0.9 kbp Xbal-SnaBI restriction fragment and replace these fragments with the Act1 5' intron and Act1/Gus translation fusion junction region from plasmid pBCG-A4 (containing an optimized translation initiation region and Ncol site at the Act1/Gus start codon) to produce plasmids pDX117 (from pDX107) and pDX119 (from pDX 109); (4) to remove the Pinll promoter- Actl 5' intron-Actl optimized start codon region from pDX117 and a 1.5 kbp Pstl-Ncol restriction fragment and use this to replace the Act15' region of the Act1 -based expression vectors pCOR102 and pCOR116 to produce the plasmids pDX202 (from pCOR102) and pDX216 (from pDX116); (5) to remove the Pinll promoter and Act1 5' intron from pDX216 and a 1.5 kbp Accl restriction fragment and use this to replace the Act1 5^* region of the Act1 -based expression vector pCOR117 to produce the plasmid pDX217; (6) to isolate the Pinll promoter and Act1 5' intron as a 1.5 kbp Sall-Spel restriction fragment and use this to replace the Act1 5' region of pDX316 to produce the plasmid pDX427; (7) to isolate the 1 kbp Pinll 3" end from pDX316 and add this to pDX202 as an EcoRV-Apal restriction fragment to produce translational fusion vector pDX402, or to add this to pDX216 as a Ncol-Sphl restriction fragment to produce translational fusion vector pDX416, or to add this to pDX217 as a Spel-Sphl restriction fragment to produce transcriptional fusion vector pDX417.

Plasmids pDX227, pDX202, pDX216, and pDX217 each contain the Pinll promoter and Act15' intron followed by a polylinker sequence into which the foreign gene of interest (with its own 3' transcription terminator region) may be cloned. Plasmids pDX427, pDX402, pDX416 and pDX417 each contain a Pinll 3' transcription terminator region following their Pinll promoter and Act1 5' intron with a polylinker between the intron and 3'-end regions into which the coding region of the foreign gene of interest may be cloned. Different expression vectors according to the present invention, each containing several different restriction sites facilitate the cloning of useful foreign genes and subsequent manipulation of the resulting recombinant DNA molecules.

Each plasmid pDX227/pDX427, pDX202/pDX402, and pDX216/pDX416 according to the present invention contains an Act1 translation initiation codon in their polylinker region. These plasmids can be used for the creation of translation fusion constructs. Modification of the translation initiation codon region of the foreign genes of interest to create a Ncol restriction site facilitates the creation of fusion constructs using the pDX202/pDX402 and pDX216/pDX416 plasmids. In addition to having a wide variety of cloning sites in their respective polylinker regions, each of the translation fusion vectors according to the present invention contains a unique blunt-ended restriction site into which any suitably prepared foreign gene of interest may be cloned. As will become apparent to those skilled in the art examining the lower part of figure 2, blunt ended restriction sites (EcoRV or Smai) are found in all three possible reading frames permitting the creation of translational fusion constructs with any suitably treated foreign gene of interest.

As will also become apparent to those skilled in the art, the transcriptional fusion vectors pDX217/pDX417 according to the present invention can be used to clone foreign genes that cannot tolerate N-terminal amino acid additions. Each vector contains no translation initiation codon. In addition to a choice of restriction sites in their respective polylinker region, they may each contain a unique blunt-ended restriction site (REcoRV, underlined) for the cloning of any suitable foreign gene of interest.

In addition, as will become apparent to those skilled in the art, viral translational enhancers, such as the alfalfa mosaic virus (AMV) enhancer [see Nature 325:622 (1987)], may also be included in the Pinll expression vectors according to the present invention.

Specific chimeric plasmids according to the present invention may be constructed along a number of lines. For example, in making the Pinll-Act1 5' intron-Pinll gene construct according to the present invention, the constructs include:

Pinll promoter-Actl 5' intron-Pinll gene-Pinll 3' region; and Pinll promoter-Actl 5' intron-Pinll gene-Nos 3' region. Similarly, CPTi gene (Agricultural Genetics Company) containing constructs were made as above with the exception that the CPTi gene was substituted for the Pinll gene.

Pinll-Act1 5' intron B.t. toxin-Nos 3' constructs were also prepared. In these constructs, a B.t. toxin gene (Agracetus) was used which contains a truncated delta endotoxin HD-1 gene preceded by an AMV translational enhancer, and the B.t. toxin gene and the AMV enhancer was placed downstream from the Pinll- Act1 5' intron. Another construct was prepared using a B.t. toxin (KC) gene was tested for insect killing activity and found to have a relatively broad host range against different species of insects. In addition, as is apparent to those skilled in the art, it is possible to provide Pinll-Actl 5' intron-Pinll gene constructs according to the present invention containing an anti-viral DNA. Thus, the wound inducible promoter system according to the present invention can be expanded to include the control of insect-transmitted viral diseases. For example, the tungro virus infection of rice plants requires that participation of an insect vector. As the constructs according to the present invention may easily be modified by adding foreign DNA to the construct, by adding the anti-tungro viral DNA to a basic construct according to the present invention (Pinll-Act1 5' intron-Pinll gene-Nos 3' region), and transform rice with this construct, the regenerated transgenic plants will synthesize very little Pinll protein and anti-viral DNA. However, after insects bite the plants, large amounts of the Pinll protein is produced to deter further insect attack, and the anti-viral DNA is produced to inhibit virus replication or production.

Although a number of protocols exist for transforming plants with the plasmid vectors according to the present invention, two such techniques which have been successful are the transformation of protoplasts using polyethylene glycol, and the transformation of suspended cell cultures using the DNA particle gun. Act1-bar constructs may also be used for co- transformation and for selecting regenerated calli that are resistant to 4-8 mg/liter of glufosinate ammonia.

In addition to the wound inducible gene promoter (Pinll promoter) described above, a number of other wound indicuble genes have been cloned and characterized from dicot plants by other investigators. For example, the genomic clones corresponding to Win1 asnd Win2 have been cloned from potato [see EMBO 9:593 (1990); and Mol. Gen. Genet. 215:200 (1989). In view of our finding that the Pinll-Act1 chimeric system works in monocots, it is to be reasonably expected that the promoters of other wound inducible genes, such as Win1 and Win2, will also work in monocots, and thus other promoters of wound inducible genes are to be considered within the scope of the present invention.

Thus, while we have illustrated and described the preferred embodiment of our invention, it is to be understood that this invention is capable of variation and modification and we therefore do not wish or intend ourselves to be limited to the precise terms set forth, but desire to avail ourselves of such changes and alterations which may be made for adapting the invention to various usages and conditions. Accordingly, such changes and alterations are properly intended to be within the full range of equivalents, and therefore within the purview of the following claims. The following sequence list provides a separate description of the nucleic acid sequences described herein:

SEQUENCE LISTING

(1) GENERAL INFORMATION:

(i) APPLICANT: Cornell Research Foundation, Inc. (ii) TITLE OF INVENTION: Monocot Having Dicot Wound

Inducible Promoter

(Hi) NUMBER OF SEQUENCES: 3

(2) INFORMATION FOR SEQ ID NO:1 :

(i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 25 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS:. single (ii) MOLECULE TYPE: DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:1 : GTAGACC ATG GCT GAC GCC GAG GAT 25

(2) INFORMATION FOR SEQ ID NO:2:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 20 base pairs

(B) TYPE: nucleic acid (C) STRANDEDNESS: single

(ii) MOLECULE TYPE: DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:

GTAGACC ATG GCC GCG GGA T 20

(2) INFORMATION FOR SEQ ID NO:3: (i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 36 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(ii) MOLECULE TYPE: DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3: GTAG G ATG GCT GAC GCC GAG GAT GGG GGA TCC CC 36

Having thus described our invention and the manner and a process of making and using it in such clear, full, concise and exact terms so as to enable any person skilled in the art to which it pertains, or with which it is mostly nearly connected, to make and use the same;

SEQUENCE LISTING

(1) GENERAL INFORMATION:

(i) APPLICANT: Cornell Research Foundation, Inc.

(ii) TITLE OF INVENTION: Monocot Having Dicot Wound

Inducible Promoter

(Hi) NUMBER OF SEQUENCES: 3 (iv) CORRESPONDENCE ADDRESS:

(A) ADDRESSEE: Yahwak & Associates

(B) STREET: 25 Skytop Drive

(C) CITY: Trumbull

(D) STATE: Connecticutt

(E) COUNTRY: USA

(F) ZIP: 0661 1

(v) COMPUTER READABLE FORM:

(A) MEDIUM TYPE: floppy disk

(B) COMPUTER: Macintosh

(C) OPERATING SYSTEM: MS-DOS

(D) SOFTWARE: Microsoft Word 4.0

(vi) CURRENT APPLICATION DATA:

(A) APPLICATION NUMBER:

(B) FILING DATE:

(C) CLASSIFICATION:

(viii) ATTORNEY/AGENT INFORMATION:

(A) NAME: George M. Yahwak

(B) REGISTRATION NUMBER: 26,824

(C) REFERENCE NUMBER: CRF D-1155 (ix) TELECOMMUNICATION INFORMATION:

(A) TELEPHONE: (203)268-1951

(B) TELEFAX: (203)268-1951

(2) INFORMATION FOR SEQ ID NO:1 :

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 25 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(ii) MOLECULE TYPE: DNA (xi) SEQUENCE DESCRIPTION: SEQ ID N0:1 :

GTAGACC ATG GCT GAC GCC GAG GAT 25

(2) INFORMATION FOR SEQ ID NO:2:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 20 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(ii) MOLECULE TYPE: DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:2:

GTAGACC ATG GCC GCG GGA T 20 (2) INFORMATION FOR SEQ ID NO:3:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 36 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(ii) MOLECULE TYPE: DNA

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:

GTAGAAG ATG GCT GAC GCC GAG GAT GGG GGA TCC CC 36

Claims

WE CLAIM:

1. A promoter system for expression of a dicot wound inducible promoter in transformed monocotyledonous plants which comprises, in linear order, a potato inhibitor II promoter gene, a DNA sequence comprising a δ'-transcribed region of a rice Act1 gene, a foreign gene of interest, and a transcriptional terminator sequence.

2. A transgenic monocotyledonous plant having a genome comprising, in linear order, a potato inhibitor II promoter gene, a DNA sequence comprising a δ'-transcribed region of a rice Act1 gene, a foreign gene of interest, and a transcriptional terminator sequence.

3. A genomic sequence comprising a fragment having a restriction map selected from:

Pstl Xbal

1 I \ J ⁾ t > > > > ⁾ > > > > ⁾ > ^} > ' i ⁾

Pinll 5' region GUS coding region Pinll 3' region pUC19

SUBSTITUTE SHEET

Pstl Xbal Smal

wherein Gus coding region may be a β-glucuronidase reporter gene or a foreign gene of interest.

SUBSTITUTE SHEET